Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-May-24 4:04 PM View:  | Akebia Therapeutics, Inc. (AKBA) | 13-May-24 | Sale (Planned) | 34,840 | $1.26 | $43,898.40 | (5%) 706.93K to 672.09K | |
| 01-Mar-24 5:49 PM View: | Akebia Therapeutics, Inc. (AKBA) | 29-Feb-24 | Sale | 8,661 | $1.58 | $13,684.40 | (1%) 715.59K to 706.93K | |
| 29-Feb-24 6:02 PM View: | Akebia Therapeutics, Inc. (AKBA) | 27-Feb-24 | Sale | 10,744 | $1.52 | $16,330.90 | (1%) 726.34K to 715.59K | |
| 02-Feb-24 4:11 PM View: | Akebia Therapeutics, Inc. (AKBA) | 31-Jan-24 | Grant | 149,300 | -- | -- | 26% 577.04K to 726.34K | |
| 25-May-23 9:01 PM View: | Akebia Therapeutics, Inc. (AKBA) | 25-May-23 | Sale | 95,478 | $1.22 | $116,760.00 | (14%) 669.51K to 574.04K | |
| 25-May-23 9:01 PM View: | Akebia Therapeutics, Inc. (AKBA) | 24-May-23 | Grant | 200,000 | -- | -- | 43% 469.51K to 669.51K | |
| 16-May-23 4:09 PM View: | Akebia Therapeutics, Inc. (AKBA) | 12-May-23 | Grant | 200,000 | -- | -- | 74% 269.51K to 469.51K | |
| 03-Mar-23 8:01 AM View: | Akebia Therapeutics, Inc. (AKBA) | 01-Mar-23 | Sale | 20,412 | $0.88 | $17,911.50 | (7%) 289.93K to 269.51K | |
| 01-Mar-23 4:06 PM View: | Akebia Therapeutics, Inc. (AKBA) | 27-Feb-23 | Sale | 10,090 | $0.81 | $8,205.19 | (3%) 300.02K to 289.93K | |
| 02-Mar-22 9:11 PM View: | Akebia Therapeutics, Inc. (AKBA) | 01-Mar-22 | Sale | 14,978 | $2.17 | $32,512.70 | (5%) 312.0K to 297.02K | |
| 02-Mar-22 9:11 PM View: | Akebia Therapeutics, Inc. (AKBA) | 28-Feb-22 | Grant | 50,000 | -- | -- | 19% 265.55K to 315.55K | |
| 02-Mar-22 9:11 PM View: | Akebia Therapeutics, Inc. (AKBA) | 28-Feb-22 | Sale | 6,555 | $2.15 | $14,124.70 | (2%) 315.55K to 309.0K | |
| 01-Apr-21 8:33 PM View: | Akebia Therapeutics, Inc. (AKBA) | 01-Apr-21 | Market Sale | 1,211 | $3.40 | $4,117.40 | (< 1%) 266.76K to 265.55K | < 1% |
| 18-Mar-21 7:17 PM View: | Akebia Therapeutics, Inc. (AKBA) | 16-Mar-21 | Grant | 11,648 | -- | -- | 5% 255.11K to 266.76K | |
| 02-Mar-21 4:08 PM View: | Akebia Therapeutics, Inc. (AKBA) | 01-Mar-21 | Market Sale | 14,547 | $3.40 | $49,403.10 | (5%) 269.66K to 255.11K | |
| 02-Mar-21 4:08 PM View: | Akebia Therapeutics, Inc. (AKBA) | 26-Feb-21 | Grant | 62,000 | -- | -- | 30% 207.66K to 269.66K | |
| 02-Mar-20 7:29 PM View: | Akebia Therapeutics, Inc. (AKBA) | 28-Feb-20 | Grant | 65,000 | -- | -- | 44% 146.93K to 211.93K | |
| 02-Mar-20 7:29 PM View: | Akebia Therapeutics, Inc. (AKBA) | 28-Feb-20 | Market Sale | 6,972 | $8.70 | $60,656.40 | (3%) 211.93K to 204.96K | 65% |
| 12-Apr-19 4:01 PM View: | Akebia Therapeutics, Inc. (AKBA) | 11-Apr-19 | Disposition | 11,909 | $7.70 | $91,699.30 | (7%) 158.84K to 146.93K | 61% |
| 05-Mar-19 10:00 PM View: | Akebia Therapeutics, Inc. (AKBA) | 28-Feb-19 | Grant | 65,000 | -- | -- | 69% 93.84K to 158.84K | |
| 13-Dec-18 8:14 AM View: | Akebia Therapeutics, Inc. (AKBA) | 12-Dec-18 | Payment of Exercise | 23,385 | $8.94 | $209,062.00 | (20%) 117.23K to 93.84K | 66% |
| 02-Mar-18 4:16 PM View: | Akebia Therapeutics, Inc. (AKBA) | 28-Feb-18 | Grant | 19,400 | -- | -- | 20% 95.83K to 115.23K | |
| 04-Oct-17 4:20 PM View: | Akebia Therapeutics, Inc. (AKBA) | 02-Oct-17 | Market Sale (Planned) | 1,398 | $19.64 | $27,456.70 | (1%) 97.22K to 95.83K | 85% |
| 02-Oct-17 4:04 PM View: | Akebia Therapeutics, Inc. (AKBA) | 28-Sep-17 | Market Sale (Planned) | 5,000 | $19.30 | $96,500.00 | (5%) 102.22K to 97.22K | 84% |
| 17-Aug-17 4:06 PM View: | Akebia Therapeutics, Inc. (AKBA) | 15-Aug-17 | Market Sale (Planned) | 5,000 | $15.00 | $75,000.00 | (5%) 107.22K to 102.22K | 80% |
| 06-Jul-17 12:25 PM View: | Akebia Therapeutics, Inc. (AKBA) | 03-Jul-17 | Market Sale | 1,399 | $14.26 | $19,946.50 | (1%) 108.62K to 107.22K | 79% |
| 04-Apr-17 4:01 PM View: | Akebia Therapeutics, Inc. (AKBA) | 03-Apr-17 | Market Sale | 1,401 | $9.18 | $12,857.70 | (1%) 110.02K to 108.62K | 67% |
| 23-Feb-17 4:03 PM View: | Akebia Therapeutics, Inc. (AKBA) | 21-Feb-17 | Grant | 39,500 | -- | -- | 56% 70.52K to 110.02K | |
| 03-Jan-17 4:02 PM View: | Akebia Therapeutics, Inc. (AKBA) | 01-Jan-17 | Market Sale | 1,629 | $10.49 | $17,089.20 | (2%) 72.15K to 70.52K | 71% |
| 04-Oct-16 4:12 PM View: | Akebia Therapeutics, Inc. (AKBA) | 01-Oct-16 | Market Sale | 1,401 | $8.95 | $12,545.70 | (2%) 73.55K to 72.15K | 68% |
| 06-Jul-16 4:08 PM View: | Akebia Therapeutics, Inc. (AKBA) | 05-Jul-16 | Market Sale | 1,402 | $7.47 | $10,468.00 | (2%) 74.96K to 73.55K | 62% |
| 05-Apr-16 4:01 PM View: | Akebia Therapeutics, Inc. (AKBA) | 04-Apr-16 | Market Sale | 1,401 | $9.41 | $13,183.40 | (2%) 76.36K to 74.96K | 70% |